re: Ann: Patrys to Initiate Clinical Trial wi... FatHarry the one up for Onyx is Kyprolis was approved by FDA 12 months before the aquisition materialized. The up for Patrys is even at $1 its less than 5% of what Amgen paid ---- it has Orphan Designation to speed through trial completion & approval in both Eu & US. Amgen still has plenty of bank & if they work favourably in unison you can bet your bottom dollar Amgen will move to put both together to really go head on in competition with Celgene.
Ann: Patrys to Initiate Clinical Trial with Onyx , page-11
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.229M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $5.431K | 1.357M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 26519870 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 7889760 | 12 |
View Market Depth
| Last trade - 11.23am 15/11/2024 (20 minute delay) ? |
| PAB (ASX) Chart |